CompletedNot applicableNCT01744561
Effects of a Partially Supervised Conditioning Program in CF
Studying Cystic fibrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Wuerzburg University Hospital
- Principal Investigator
- Helge U Hebestreit, Dr. med.Wuerzburg University Hosptitals
- Intervention
- Exercise Intervention(behavioral)
- Enrollment
- 155 enrolled
- Eligibility
- 12 years · All sexes
- Timeline
- 2014 – 2018
Study locations (28)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
- Mukoviszidose-Ambulanz, Universitätsklinik für Kinder- und Jugendheilkunde,, Graz, Austria
- Cystische Fibrose Zentrum für Kinder, Jugendliche und Erwachsene, Innsbruck, Austria
- Montreal Children's Hospital, McGill University Health Centre - Glen Site, Monrtreal, Quebec, Canada
- Hôpital Renée Sabran, Service : Maladies respiratoires, Hyères, France
- Hôpital Calmette, Service Pneumologie-immuno-allergologie boulevard du Pr Leclercq, Lille, France
- Hôpital Jeanne de Flandre, Service: Pneumologie et allergologie pédiatriques, Lille, France
- Hôpital Arnaud de Villeneuve, Service: Maladies respiratoires, Montpellier, France
- Hôpital Necker, Service : Pneumologie et allergologie pédiatriques, Paris, France
- Hôpital Maison Blanche, Service : Maladies respiratoires, Reims, France
- Olgahospital, Klinikum Stuttgart, Stuttgart, Baden-Wurttemberg, Germany
- Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Tübingen, Tübingen, Baden-Wurttemberg, Germany
- Children´s Hospital of the University, Würzburg, Bavaria, Germany
- Pediatric Pulmonology and CF centre, Children´s Hospital, Ruhr University, Bochum, Germany
- +13 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01744561 on ClinicalTrials.govOther trials for Cystic fibrosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07437105Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy ParticipantsVertex Pharmaceuticals Incorporated
- RECRUITINGNANCT07436351ACT With CF Self-Help ToolkitThomas Jefferson University
- RECRUITINGNCT07369414Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure Risk at HomeResearch Center Borstel
- RECRUITINGNANCT07314229Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-IvacaftorUniversity Hospital, Lille
- RECRUITINGNCT07083557Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)Bettina Mittendorfer
- RECRUITINGNCT07505797ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)iSono Health, Inc.
- RECRUITINGPHASE1NCT07283770Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy ParticipantsVertex Pharmaceuticals Incorporated
- RECRUITINGNCT07363304Impact of Elexacaftor-Tezacaftor-Ivacaftor Treatment on Metabolic, Epigenetic and Fecal Microbiota Profiles in People With Cystic Fibrosis.Meyer Children's Hospital IRCCS